Comments

Entrada Therapeutics Stock News

TRDANASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$11.31
0.292.58%
Last update: Dec 16, 3:29 PM
Overview

News

EarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report

Latest Entrada Therapeutics Stock News | NASDAQ:TRDA | Benzinga

Get the latest news on Entrada Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Entrada Therapeutics performance

People Also Watch

Galectin Therapeutics Inc
NASDAQ:GALT
$6.09
-6.45%
Monopar Therapeutics Inc
NASDAQ:MNPR
$70.78
-5.78%
Immuneering Corp
NASDAQ:IMRX
$5.76
-0.35%
PepGen Inc
NASDAQ:PEPG
$5.59
2.19%
DiaMedica Therapeutics Inc
NASDAQ:DMAC
$8.77
1.15%
Kyverna Therapeutics Inc
NASDAQ:KYTX
$10.61
-1.94%
Bicycle Therapeutics PLC
NASDAQ:BCYC
$7.30
-0.41%
Lineage Cell Therapeutics Inc
AMEX:LCTX
$1.78
3.49%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
Š 2025 Benzinga | All Rights Reserved